Theravance Biopharma, Inc., a biopharmaceutical company, develops and commercializes medicines in the United States. It offers YUPELRI, an once-daily, nebulized long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease (COPD); and Ampreloxetine an investigational...
16 insider purchases on record · latest filing 2024-08-09.
Insiders have also filed 80 sale transactions at TBPH.